300677 英科医疗
2024/03 - 三个月
人民幣(K¥)
与去年同期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)
营业总收入2,203,08740.06%6,918,7246,613,81416,240,09413,836,715
减:营业总成本1,987,46613.93%6,753,5606,051,3327,580,9255,472,759
    其中:营业成本1,748,21120.39%5,971,0235,745,7176,251,6264,285,310
               财务费用(46,770)-207.29%(306,436)(627,253)(19,180)265,411
               资产减值损失(367)--(5,349)(44,038)(5,744)(1,434)
公允价值变动收益64,168-1,609.83%175,56759,67032,6613,176
投资收益20,89129.72%87,44683,27128,4584,710
    其中:对联营企业和合营企业的投资收益------------
营业利润293,163-295.31%438,990707,1848,688,7258,368,929
利润总额292,359-288.57%442,818704,4148,648,6938,346,638
减:所得税费用51,793-725.95%54,75365,0711,185,2211,342,127
净利润240,566-263.91%388,065639,3437,463,4717,004,511
减:非控股权益2,368-62.34%5,06710,27333,395(2,537)
股东净利润238,198-255.63%382,998629,0707,430,0767,007,048

市场价值指针
每股收益 (元) *0.360-256.52%0.5800.95011.33014.650
每股派息 (元) *----0.0800.1000.7503.500
每股净资产 (元) *25.1285.89%24.43423.96528.87926.498
审计意见 #--标准的无保留意见标准的无保留意见标准的无保留意见标准的无保留意见
回页顶
备注: *未调整数据
#只提供简体内容